The market’s gapping down a little this morning. The Qs are still above yesterday’s low though. So I’ll be watching for a break of that support. I probably won’t play the long side unless the Qs trade above yesterday’s close.
(I have another batch of StockTickr invites — get ‘em while they’re hot…)
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on disappointing earnings/guidance: UARM -12%, MGAM -11%, BMHC -6.5%, ATVI -6% (also Citigroup downgrades to Sell), JCOM -6%, TOL -4.1% (guidance only, down in sympathy: KBH -2.7%), RL -3.4%, BP -3.4%, NBR -2.7% (also Merrill downgrade), ACTS -2.7%… Other News: CNXT -10% (jury rules that co infringed patents), PAL -7%, SSL -4.8%, DAVE -4.5% (stock ran up on speculation Cramer would profile, but profiled TXRH instead), BBBB -4.3% (BofA downgrade), GTOP -3.7% (prices offering), PAAS -3.5%, PALM -3.5% (Lehman downgrade), PTEN -3.4% (Merrill downgrades to Sell), JBLU -2.4% (Morgan Stanley downgrade), REDF -2.2%, GFI -2.8%, X -1.7% (profit taking after 6% move yesterday).
Gapping Up
Gapping up on strong earnings/guidance: SOHU +11% (also Piper upgrade), IGLD +10%, NAT +6%, RIGL +3.7%, BRKS +2.8% (also Needham upgrade), DIS +2.4% (also CIBC upgrade), AL +2.4%, LVLT +1.9%, ICCC +26%… Other News: PCNTF +20% (being picked up as a REDF play), MOCC +11% (extends yesterday’s 13% move), GEMS +8% (LEAP contract), SJR +8%, CTDC +7% (bounces after 35% drop yesterday), TXRH +6.5% (Mad Money mention), GERN +5.2% (announces commercial launch of cell line), VRTX +5.1% (successfully completes key studies with VX-950), NABI +5% (positive phase I results), VPHM +4.1% (FDA grants fast track status for Maribavir), SIFY +3.5% (momentum), GNTA +3.5% (momentum), RFMD +3.3% (ships its 20 millionth transceiver), GILTF +3% (selected by China Unicom), GM +2% (describes turnaround plan, lowers dividend), FOSL +1.7% (Matrix upgrade), BCSI +1.4% (Roth upgrade), MEDI +1.4%, AAPL +1.3% (unveils new 1GB iPod nano at $149; to offer Showtime on iTunes)… Under $3: RNDC +30% (to be acquired), MBAY +22% (to review strategic options), NASI +20% (prostate treatment gets FDA approval), GNBT +7.5%.
Disclaimer & How I use this list
Thanks for the Stoktickr invite!